http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2264101-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee1c19da359446fb5c4f0458a57b783d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e45efeaa6a34dfd9d44fa29a7fe0c806
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
filingDate 1997-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e3cfbca63c3ed2a8bf8058b94eb3423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa58bdec613fd53bffa27c2f69ba30e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90cbf75acb6b37bdb338d51a2383678a
publicationDate 1998-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2264101-A1
titleOfInvention Preventives/remedies for muscle tissue degenerations
abstract Preventives/remedies for muscle tissue degenerations containing as the active ingredient quinoline compounds represented by general formula (I) or pharmaceutically acceptable salts thereof. The preventives/remedies exert remarkable inhibitory and improving effects on muscle tissue degenerations such as necrosis, fibrosis or calcification. Thus, they are useful in the prevention and treatment of, in particular, cardiomyopathy, muscular dystrophy, pulmonary fibrosis, etc.
priorityDate 1996-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492078
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21889244
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID24179
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396411
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394889
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2520
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45266664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3637
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135403646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457444288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3806114
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409343598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481582
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393598
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457484072
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457313472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455992047
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419565336
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412389932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410550225
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419761517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5839
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4893
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID183
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5581
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414858657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458399660
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9958907

Total number of triples: 51.